Digital microfluidic biochips have emerged as a popular alternative for laboratory experiments. To make the biochip feasible for practical applications, pin-count reduction is a key problem to higher-level integration of reactions on a biochip. Most previous works approach the problem by post-processing the placement and routing solutions to share compatible control signals; however, the quality of such sharing algorithms is inevitably limited by the placement and routing solutions. We present in this paper a comprehensive pin-constrained biochip design flow that addresses the pin-count issue at all design stages. The proposed flow consists of three major stages: (1) pin-count aware stage assignment that partitions the reactions in the given bioassay into execution stages, (2) pin-count aware device assignment that determines a specific device used for each reaction, and (3) guided placement, routing, and pin assignment that utilize the pin-count saving properties from the stage and device assignments to optimize the assay time and pin count. For both the stage and device assignments, exact ILP formulations and effective solution-space reduction schemes are proposed to minimize the assay time and pin count. Experimental results show the efficiency of our algorithms/flow and a 55-57% pin-count reduction over the state-ofthe-art algorithms/flow.
INTRODUCTION
Digital microfluidic biochips, also referred to as lab-on-a-chip or biochips, have emerged as an alternative for conventional laboratory experiments. With lower cost and higher immunity to human errors, the technology is gaining increasing applications including DNA sequencing, immunoassays, environmental toxicity monitoring, and point-of-care diagnosis of diseases [8] .
Recently, the second-generation (digital) microfluidic biochips have been proposed [5, 12] . Typically, a digital microfluidic biochip consists of a two-dimensional (2D) electrode array and peripheral devices (optical detection sites, dispensing ports, etc.) [5] . On a digital microfluidic biochip, movements of the droplets are controlled by the electrohydrodynamic force generated by the electrodes. By assigning time-varying voltage values to turn on/off the electrodes on the digital microfluidic biochip, we can move the droplets around the entire 2D array and perform fundamental microfluidic operations (i.e., mixing reactions) for different bioassays. These operations performed under the control of the electrodes are also called reconfigurable operations because of their flexibility in area (electrodes involved) and in execution time. A reconfigurable operation can be carried out anywhere on the 2D plane. And it can be completed, for example, slowly with 4 electrodes, or faster with 8 electrodes.
The reconfigurability of the operations, as it brings about the freedom in design, raises issues both in scheduling and in electrode control. For a given bioassay, different completion time and resource requirements can be achieved by changing the time and location schedule of the involved operations. Therefore, it has raised active design automation discussions in the past few years [10, 11, 18] . On the other hand, as the chip size grows, it becomes necessary to restructure the electrode control mechanism, or the unlimited number of control signals will be impossible to be implemented.
Originally, the electrodes are addressed and controlled independently, that is, each electrode is assigned a dedicated control pin. This kind of biochips, which are also referred to as direct-addressing biochips, provide great flexibility for droplet movement; yet they suffer from the increasing design complexity. Specifically, the routing problem for the large number of control pins has made this architecture only applicable to small-scale biochips [14] .
Lately, alternative driving schemes have been proposed to alleviate the growth of the required number of control pins. Pinconstrained digital microfluidic biochips [8] , one of the major genres of the pin-count reduction approaches, reduce the number of pins to be routed to the electrodes by assigning each control pin to multiple electrodes; that is, multiple electrodes are controlled by a single control signal, and thus they are turned on/off simultaneously. Regarding this, efforts have been made to cluster the electrodes that can be controlled together without introducing unexpected droplet behaviors [14, 16] .
However, these currently available pin-count reduction methods focus on the electrode partitioning, control signal merging, and pin assignment as the last step of the design flow, while the feasibility and effectiveness of such methods actually depend on the scheduling, placement, and routing results of the given design. Therefore, it is desirable to consider the pin-count constraint at earlier stages of the pin-constrained biochip design flow. Consequently, we propose in this paper a novel pin-count aware design flow for pin-constrained biochips and efficient algorithms for the corresponding steps in the flow.
Previous Work
Previous works on the pin-constrained biochip problem generally address the problem after the biochip is placed and routed, and its design flow is illustrated in Figure 1(a) . The flow consists of three major stages. The first stage, referred to as scheduling or placement, assigns the time slots and electrodes to each reactions in the bioassay and are resolved in [4, 7, 11, 18] . The second stage, routing, determines the paths that the droplets move around the biochip and are worked out in [2, 3, 6, 13, 17] . Note that the solutions for these two stages are designed for direct-addressing biochips and do not address the pin-count constraint. Finally the electrode partitioning or control signal merging, followed by pin assignment, in [14, 16] , is used to reduce the final pin count. A fundamental problem with the previous flow is that only the last stage of the flow is pin-count aware, while the properties of the scheduling, placement, and routing results do affect the space for pin-count reduction. Currently, due to the lacking of specialized front-end design automation methods for pin-constrained biochips, these properties cannot be maintained/utilized well, and thus the quality of the pin-reduction will inevitably be restricted. 
Our Contributions
Unlike the previous flow that addresses the pin-constrained issue at the last stage, we propose in this paper a novel comprehensive pin-count aware design flow. The flow is summarized in Figure 1 (b) and will be detailed in Section 2. It consists of three major stages: (1) pin-count aware stage assignment, (2) pin-count aware device assignment, and (3) guided placement, routing, and pin assignment. Besides adding the pin-count considerations into the flow, we expand the scheduling stage into stage assignment and device assignment to reflect their criticality in pin-count reduction. For both stages, we propose exact ILP formulations and effective reduction methods to minimize the assay completion time and the pin count. As mentioned earlier, pin-count saving properties should be maintained along the design flow. We also present guidelines for the placement, routing, and pin assignment to maintain the low pin-count properties obtained earlier at the assignment stage.
With the flow and the algorithms for realizing these properties, our contributions can be summarized as follows.
• We propose a dedicated pin-count aware design flow for pinconstrained biochips to consider the pin count throughout all stages of the flow.
• We identify the factors that would affect the pin count along the design and explore the properties that are favorable for pin-count reduction. The properties are universal to the pin-constrained biochips and would be helpful for future development with our and other design flows.
• We derive an exact ILP formulation for stage assignment that models the synchronous control of reactions and minimize the assay completion time. We also provide an effective scheme to reduce the problem size and an approximation to reduce the assay time to speed up the process.
• We derive an exact ILP formulation for device assignment that minimizes the number of branches from a device fanout, which reduces the corresponding pin-count demand, potential routing complexity, and fault tolerance. A corresponding problem size reduction method is also provided to lower the runtime.
• We present the guidelines for placement, routing, and pin assignment that maintain the minimized pin count derived by the stage and device assignments.
The experimental results show the efficiency of our algorithms for different bioassays (and with different device selections). As our method provides more flexible device count/type choices, we also achieve 55-57% pin-count reductions over the previous works [14, 16] , which is a very significant improvement and justifies the effectiveness of our design flow/algorithms.
The remainder of this paper is organized as follows. Section 2 analyzes the control-pin demand and gives the overall design flow. Sections 3 and 4 detail the ILP formulation and problem reduction for stage assignment and device assignment, respectively. Section 5 provides the guidelines for follow-up placement, routing, and pin assignment. Finally, the experimental results and conclusions are given in Sections 6 and 7, respectively.
PIN DEMAND AND PROPOSED FLOW

Figure 2: Classification of electrodes.
We classify the demand of pins N p into three categories:
where P reaction , P branching , and P routing , are the the numbers of pins needed to control the electrodes for reactions, for output branchings from devices, and for routing, respectively. Figure 2 illustrates the classification of electrodes. Although the control signals of these three categories of pins may be further merged, we shall focus on minimizing the three terms before the merging. Our design flow shown in Figure 1 (b) consists of the following three major stages:
1. Stage assignment: This stage minimizes P reaction by aligning reactions to execution stages and thus enables the synchronous control of the reactions. For the example bioassay in Figure 3 (a), a possible stage assignment result is shown in Figure 3 (b). Note that although we represent the generation and optical detection as black boxes in the simplified figure, we also assign corresponding stages to them. In the stage assignment, except for sharing the control pins, we also have to minimize the assay completion time to reduce the execution time overhead introduced during this stage. The constraints and considerations for stage assignment will be detailed in Section 3. 2. Device assignment: This stage minimizes P branching by matching the reactions to specific devices. Device assignment is important because different matchings can lead to different feeding relationships between devices and thus affects the number of independent control pins needed for the branchings between devices. A possible device assignment for Figure 3 (b) is shown in Figure 3 (c), and the device assignment problem will be addressed in Section 4. 3. Guided placement, routing, and pin assignment: This stage transforms the stage and device assignment result to actual placement and routing solutions. Following the proposed guideline with careful pin assignment can maintain P routing as a constant. The differences of the proposed flow from the previous one are that the pin-count concerns are considered from the early stages to the end of the flow, and the scheduling problem is expanded to address two major sources of control pin demand.
STAGE ASSIGNMENT
This section first introduces the idea of synchronous reactions and the corresponding tradeoff between execution time and pin count. Next, we describe the stage assignment problem that attempts to minimize the assay completion time with the synchronously controlled reactions. Then we present the exact ILP formulation for the stage assignment. Finally, the corresponding solution space reduction schemes and an approximation for execution time are provided to speed up the runtime.
Advantage of Synchronous Reactions
The motivation for stage assignment is to reduce P reaction by synchronously controlling the reactions assigned to the same stage, while keeping the assay completion time minimized. The differences between asynchronous and synchronous control can be explained by Figure 4 . In Figure 4 (a), Mixers 1 and 2 are controlled separately and do not share a control pin; that is, the mixers can decide when to begin and cease their mixing reactions independently. We can see that R 3 can use Mixer 1 right after R 1 is completed, and thus the completion time is shorter. However, Mixers 1 and 2 cannot share a control pin in this way.
On the other hand, in Figure 4 (b), Mixers 1 and 2 are controlled together, which means that the mixers must begin and cease their mixing reactions synchronously. Therefore, although R 1 and R 2 take different completion times, the synchronized control signals will cease the reactions only when the slower reaction ends. Thus, R 3 can begin only after R 2 is completed, at the same time as R 4 . Despite the execution time overhead, in this case, Mixers 1 and 2 can share their control pins, which is more favorable for pinconstrained biochips.
The Stage Assignment Problem
Given a bioassay and a chip specification, stage assignment divides the reactions into a set of execution stages, and each stage is dedicated to a single category of reactions (e.g., generation of certain sample/reagent, mixing, optical detection, etc.). Besides, the working time of each stage is also determined in stage assignment. Following are the constraints for the stage assignment.
1. Capacity constraints: The number of reactions in a stage is upper-bounded by the number of the devices belonging to the category of the stage.
Uniqueness constraints:
A reaction exists in exactly one stage.
Duration constraints:
The duration of a stage is the duration of the slowest reaction assigned to the stage. 4. Sequence constraints: Stages that belong to the same category are sorted and executed sequentially without overlapping.
Precedence constraints:
If there are data dependencies between reactions described in the bioassay such as "reaction R i must happen before reaction R j ," then the stage that includes R j can begin only after the stage of R i ends.
Note that the major differences from the previous scheduling or placement problems in [10, 11, 17] are the duration constraints and sequence constraints superimposed for synchronous control.
Different stage assignment results can lead to different assay completion times. For a given stage assignment, the minimum assay completion time can be calculated with the duration, sequence, and precedence constraints. In our stage assignment, the target is to find the stage assignment with the shortest assay completion time.
Problem Formulation for Stage Assignment
The stage assignment problem can be formulated as follows. Given: 
ILP Formulation for Stage Assignment
Denote the occurrence of Rn ∈ S m,i as g n,m,i , and follow the notion of the problem formulation, then the stage assignment problem that minimizes assay completion time Tc can be formulated as follows.
Minimize Tc Subject to 1. Capacity constraints:
2. Uniqueness constraints:
Duration constraints:
Em,i − Bm,i − Tn,mgn,m,i ≥ 0, ∀n, m, i.(4)
Sequence constraints:
Em,i 1 ≤ Bm,i 2 , ∀m, i1 < i2.(5)
Precedence constraints:
6. Assay start and finish:
In Inequality (6), Tmax is a large number used to formulate the AND logic. It can also be set to an upper bound of the minimum assay completion time obtained by greedy assignment.
Solution Space Reduction
The naive formulation shown in the previous subsection is complicated and not efficient to be solved without reduction. The number of variables and constraints are O(NMIa) and O(|Sp|M 2 I 2 a + NMIa), where Ia is the max number of stages among the device categories, which can be O(N ) without careful bounding.
Reaction Category Mapping
To reduce the problem size, we first note that a reaction is mapped to a specific category of devices, and thus we can eliminate redundant variables and constraints. That is, all g n,m,i with m = Vn can be removed, and thus all related constraints can be simplified or even abandoned. Therefore, the numbers of variables and constraints become O(NIa) and O(|Sp|I 2 a + NIa), respectively. Note that a pair in Sp actually indicates two corresponding reactions and thus two specific device categories, so we can drop the M 2 from |Sp|M 2 I 2 a .
Upper Bound for the Stage Number
Then we bound the number of stages used by each device category. The advantage is twofold. First, the effect of the Ia term on the number of variables and constraints can be effectively reduced when the number of stages is tightly bounded. On the other hand, providing a bound for the stage count can restrict the permutations of identical solutions. The exact formulas for the bound will not be presented in this paper due to the page limit.
Lower Bound for Assay Completion Time
Finally, it is helpful to add a lower bound for the assay completion time into the ILP formulation to speed up the runtime of the ILP solver. Sometimes for the case that the assay time is dominated by a few critical paths, the ILP solver may take more time to search for permutations of cells on non-critical paths even when an optimal solution is found. To avoid this situation, we can provide a lower bound by calculating the length values of all paths in advance and use the longest path to bound the assay completion time. 
Approximation for Assay Completion Time
Even with the reductions in the previous subsection, the formulation is still difficult for ILP solvers. One of the most difficult parts is the precedence constraints around B m,i and E m,i in Equation (6), in which the integer values are conditionally constrained.
To further speed up the ILP solution, we propose to apply ILP only for the stage assignment of mixing reactions, while the stage assignment of the other reactions (i.e., generation, optical detection) are implied by the related mixing reactions called priors. By doing so, we can avoid the formulation of the inter-category precedence constraints. Therefore, we only have to formulate the precedence constraints among mixing. To make sure that the minimum assay completion time obtained by the stage assignment of mixing can be used as a good approximate for the minimum execution time for the overall assay, additional constraints must be set on the distribution of the priors. However, the exact constraints for the distribution will not be presented in this paper due to the page limit.
DEVICE ASSIGNMENT
This section first explains how device assignment can affect the number of control pins needed for output branchings from devices. Next, the problem description and formulation of device assignment is introduced. Then an exact ILP formulation for the problem is presented. And finally, effective solution-space reduction schemes are proposed to speed up the process.
Effect of Device Permutation
While P reaction is handled in stage assignment, P branching is to be reduced in device assignment. To illustrate how device assignment can affect the number of branchings, Figure 5(a) shows part of a bioassay, and two possible device assignments for it are shown in Figures 5(b) and (c) . In (b), three paths {Mixer 1→ Mixer 1, Mixer 1→ Mixer 2, Mixer 2→ Mixer 1} are used, while in (c), only two paths {Mixer 1→ Mixer 1, Mixer 2→ Mixer 1} are used and thus potentially fewer electrodes are needed for controlling the branchings. Generally, device assignment can affect the routing complexity, the potential pin count, and the number of electrodes used. 
The Device Assignment Problem
Given a stage assignment result, device assignment decides, for each stage S m,i , a 1-1 mapping from the reactions in S m,i to the devices of category Dm, which minimizes the number of branchings introduced by the dependencies in Sp. Note that the sets are obtained by inserting necessary buffers to a direct stage assignment because some droplet may have to wait for a few stages before they are used, and thus the sets may be different from the setup in stage assignment by a buffer category.
Problem Formulation for Device Assignment
The device assignment problem can be formulated as follows. Given: Sr, S d , Vn, Cm, Sp, S m,i same as that from stage assignment after buffer insertion.
Find: xn,z, z ∈ [1, C Vn ], ∀Rn ∈ Sr, where xn,z is the occurrence of the event that Rn is assigned to the z-th device of the category.
That minimize: 2 ,z 2 denotes the existence of a path from the z 1 -th device of Dm 1 to the z 2 -th device of Dm 2 .
Under the following constraints:
Path usage:
For any m 1 = m 2 , z 1 ∈ [1, Cm 1 ], z 2 ∈ [1, Cm 2 ], pm 1 ,z 1 ,m 2 ,z 2 = OR ∀(Rn 1 , Rn 2 ) ∈ Sp, V n 1 = m1, Vn 2 = m2 AN D x n 1 ,z 1 , xn 2 ,z 2 .
ILP Formulation for Device Assignment
An exact ILP formulation for the device assignment problem can be written as follows.
Minimize
Subject to 1. 1-1 mapping: For any stage S m,i ,
2. Path usage:
Solution-Space Reduction
The above formulation involves O(N +M 2 ) variables and O(N + M 2 + |Sp|) constraints. Since the generation reactions can only precede mixing reactions, and the optical reactions can only follow mixing reactions in practical bioassays, we can cut the O(M 2 ) feeding relationships between devices down to O(M ); thus the numbers of variables and constraints become O(N + M ) and O(N + M + |Sp|), respectively. We further propose the following solution-space reduction schemes for the ILP formulation.
Permutation Restriction
First, we eliminate unnecessary permutations of the optimum solutions by fixing, for each device category D m, the device assignment of one of its stages with |S m,i | = Cm. Note that this is always feasible because there must be at least one stage with |S m,i | = Cm, or the Cm should be reduced because the bioassay never uses all of the devices. By doing so, assume that the original solution space is U d , the size of the new solution space after such a reduction is
Redundancy Pruning
Then we can further reduce the solution space by removing the paths around universal peripheral reactions. Here we define a category of peripheral devices Du to be universal for mixing devices Dm if and only if it is fed by all mixers of some mixing stage. In other words, each mixer must has a path to an optical detector of Du, and no matter how the priors are permuted, we need exactly Cm paths for them in the best case. Therefore, we can remove the constraints about these paths. Similarly, this method can be applied to generation categories.
Finally, we can iteratively remove uniform mixing stages and related paths from the problem. A stage is uniform if and only if it has one of the following properties.
1. All output paths from the stage are removed and the input devices for all reactions in the stage are identical. 2. All input paths to the stage are removed and the output devices for all reactions in the stage are identical.
Note that the process can be iterative because the removal of one stage could make a consecutive stage uniform.
The universal peripherals and uniform mixing stages are removed during the ILP optimization, and their optimal device assignment can be greedily decided in the reverse order of their removal. 
PLACEMENT, ROUTING, PIN ASSIGN-MENT
This section introduces the general guidelines for pin-count aware placement and routing. Following the proposed guideline with careful pin assignment can keep the low pin-count obtained by the proposed stage assignment and device assignment algorithms and keep P routing as a constant. Due to the page limit, the pin assignment method will not be covered.
Pin-Count Saving Guidelines
The major reason that the previous placement and routing methods for direct-addressing biochips do not work appropriately for the design of pin-constrained biochips is that the previous methods only preserve segregation (guarding) cells between electrodes that work during overlapping time periods; in contrast, for pin-count reduction, we also have to provide segregation cells between two electrodes that work in separate time spans. For example, electrodes E 1 and E 2 in Figure 6 are turned on for different routing paths in separate time slots, but they still cannot be controlled by the same pin because they are neighbors. Regarding this, we propose the following placement and routing guidelines.
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EXPERIMENTAL RESULTS
We implemented the proposed design flow in the C++ language with glpk [1] as our ILP solver. All of our experiments were conducted on a Linux machine with two 2.8 GHz AMD-64 CPUs and 8 GB memory.
Stage Assignment
Two practical bioassays, the in vitro diagnostics used in [10] and the colorimetric protein assay [9] , were used to evaluate our stage assignment algorithm. The experimental results for stage assignment are shown in Table 1 . Designs "in vitro 1," "in vitro 2," and "in vitro 3" are in vitro diagnostics with different numbers of samples and reagents and thus different numbers of nodes (reactions) as shown in the table, and Design "protein" is the colorimetric protein assay. For each design, we conducted stage assignment with different mixing device choices to cover both sparse and dense cases, which affect how we approximate the peripheral times. Also, we tested a mini in vitro diagnostic design "simple" with only 16 nodes just to illustrate the complexity growth of the exact ILP solution.
The runtimes of the ILP solver for both the basic formulation and the formulation after the solution-space reduction and assay time approximation are shown in Table 1 . We can see that with the basic formulation, it takes more than 1 day to solve all the cases except for "simple" and "in vitro 3" with the slowest devices. Note that even for the same design, the choice of devices can greatly affect the runtime. On the other hand, after the solutionspace reduction and assay time approximation, the ILP solver took less than one second for all cases. The quality of the assay time approximation is also shown in the table; we can see that the error is smaller than 5% for all cases, with more than half the cases achieving zero errors.
Device Assignment
We then performed device assignment with the four practical bioassays with the stage assignment results in the previous experiment as reported in Table 2 . We can see that the solution-space reduction schemes effectively reduce the number of nodes being formulated by 25% to 84%, and for all cases the optimum device assignment is obtained in less than 0.1 seconds. The results show the effectiveness and efficiency of our device assignment algorithm and the reduction scheme.
Placement and Routing Quality
With the stage and device assignment results produced by our algorithms, we also generated placement, routing, and pin assignment results for the three designs considered in [14, 16] . gives the results and comparisons. The results show that our design flow reduces 55-57% of the control pins, which justifies the effectiveness of our design flow and algorithms. 
CONCLUSIONS
We have presented in this work a pin-count aware design flow for pin-constrained biochips. ILP-based algorithms have been proposed for the stage and device assignments with effective solutionspace reductions. Guidelines for placement, routing, and pinassignment that reduce the pin count have also been discussed.
Experimental results have shown the efficiency of our algorithms and a 55-57% pin-count reduction over the previous flow that only post-processes the placement and routing results.
